Benitec Biopharma Limited (BLT.AX)

ASX - ASX Delayed Price. Currency in AUD
0.11-0.01 (-4.35%)
At close: 11:57 PM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.12
Bid0.10 x
Ask0.11 x
Day's Range0.10 - 0.12
52wk Range0.09 - 0.46
1y Target EstN/A
Market Cap16.12M
P/E Ratio (ttm)-0.63
Avg Vol (3m)243,897
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • PR Newswireyesterday

    Benitec initiates a strategic engagement with NantVentures

    NASDAQ: BNTCW) ("Benitec") announces that it has commenced a strategic engagement with NantVentures.  NantVentures was founded by Dr. Patrick Soon-Shiong and serves as the private investment arm of NantWorks and California Capital. The strategic engagement includes an immediate placement to Nant Capital, LLC, an investment entity associated with NantVentures, of 29,305,819 fully paid ordinary shares in Benitec, representing 19.99% of its existing issued capital for a post-issue holding of 16.67%.

  • PR Newswire3 months ago

    Benitec announces restructuring of Senior Executive team

    NASDAQ: BNTCW) announces the appointment of Mr Greg West as Chief Executive Officer, Dr Cliff Holloway to the combined role of Chief Business and Operating Officer and Mr Bryan Dulhunty as Chief Financial Officer.

  • PR Newswire5 months ago

    Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016

    SYDNEY, May 24, 2016 /PRNewswire/ -- Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today lodged its Interim Report for the nine months ended March 31, 2016. The report includes the ...